Golden
Zymergen

Zymergen

Zymergen, founded in 2013 and located in Emeryville, California, is a technology company providing organisms engineering services. Their biotechnology labs rely on advanced manufacturing technologies, machine learning techniques, and genomics to accelerate the design, build, test cycle of microorganisms.

Edit ID  5347620 

Dawson Sewell
Dawson Sewell edited on 13 Jul 2018 7:30 pm
Edits made to:
Timeline (+5 events) (+1846 characters)
Description (+306/-114 characters)
Article (+1917/-284 characters)
People (+6 cells) (+74 characters)
Further reading (+16/-6 cells) (+762 characters)
Documentaries, videos and podcasts (+12 cells) (+498 characters)
Categories (+2 topics)
Related Topics (+6 topics)
Topic thumbnail

Zymergen

An analytics company using machine learning techniques and lab automation to engineer microorganisms as a service.

Zymergen, founded in 2013 and located in Emeryville, California, is a technology company providing organisms engineering services. Their biotechnology labs rely on advanced manufacturing technologies, machine learning techniques, and genomics to accelerate the design, build, test cycle of microorganisms.

Article

Zymergen, founded in 2013 and located in Emeryville, California, is ana analyticstechnology company that providesproviding organismorganisms engineering services. The company'sTheir biotechnology labs rely on automation, to greatly increase the amount of metabolic and genomicadvanced datamanufacturing generatedtechnologies, and machine learningmachine learning techniques, and genomics to accelerate the design, build, test, build cycle of microorganisms. ItZymergen claims they have the worlds largest database of proprietary physical and digital DNA library in the world. The company provides their services to industrial biotechnology customers that are seeking to improve the economicscost efficiency of existing strains, or engineer new strains for, thethat manufacture of chemicals, food andor nutritionfood ingredientsadditives, and materials. The company was founded in 2011 and is headquartered in Emeryville,using Californiamicroorganisms.

Partnership, mergers and acquisitions

Radiant Genomics

On January 8, 2018 Zymergen acquired a functional metagenomics research company named Radiant Genomics. With this acquisition Zymergens gets to add the metagenomic technologies and genetic libraries developed by Radiant Genomics to it's core platform. Zymergen hopes acquiring Radiant Genomics will help accelerate it's ability to identify and create useful organisms and molecules.  The CEO of Zymergen had the following to say about the acquisition "Radiant has built an unparalleled platform and set of libraries to search genetic diversity that will allow us to search for these molecules of interest, extending our ability to produce useful molecules for materials that can transform the world around us."

Funding

Seed round

On January 1, 2014 Zymergen raised $2,000,000 in seed funding from Genoa Ventures (lead investor), Linden Mobile Ventures, Josh Perfetto, Jesse Robbins, Jenny Rooke, and David Beyer. 

Series A

On June 16, 2015 Zymergen completed their Series A funding round raising $42,000,000 in funding from Data Collective (lead investor), AME Cloud Ventures, DFJ, Genoa Ventures, Two Sigma Ventures, True Ventures, SciFI VC, Obvious Ventures, Innovation Endeavors, and Jenny Rooke. 

Series B

On October 11, 2016 Zymergen completed their Series B funding round raising $130,000,000 in funding from Soft Bank (lead investor), Two Sigma, Tao Capital Partners, Prelude Ventures, Obvious Ventures, Innovation Endeavors, ICONIQ Capital, Data Collective, DFJ, and AME Cloud Ventures. 



People

Name
Role
Related Golden topics

David St Clair

Advisor



Paul Jansen

Board member



Vonnie Estes

Board member



Further reading

Author
Title
Link
Type

Business Wire

Zymergen Acquires Metagenomics Company Radiant Genomics

News article

Clare McGrane

Bay-Area biotech startup Zymergen opens Seattle office, signaling big growth plans in the city

News article

Mark Terry

What You Need to Know About Zymergen | BioSpace

Web article

Michael J. de la Merced

SoftBank Wants to Build the Future. Here Are Some New Bets It Could Make.

News article



















Documentaries, videos and podcasts

Title
Date
Link

Designing a Million Genomes: Machine Learning, Automation and Biotech

October 7, 2015

Joshua Hoffman - CEO, Zymergen | Near Future Summit

November 15, 2016

KPMGVoice: Zymergen - The Great Rewrite | Forbes

May 4, 2017

Zymergen: Unlocking the Power of Biology through Technology - Zach Serber at impact.tech at GoogleSF

August 13, 2016

Infobox

Categories

Related Topics

Timeline

Founding of Zymergen

Zymergen, founded in 2013 and located in Emeryville, California, is a technology company providing organisms engineering services. 

Zymergen completes $2 million dollar seed funding round .

On January 1, 2014 Zymergen raised $2,000,000 in seed funding from Genoa Ventures (lead investor), Linden Mobile Ventures, Josh Perfetto, Jesse Robbins, Jenny Rooke, and David Beyer. 

Zymergen completes $42 million dollar Series A funding round.

On June 16, 2015 Zymergen completed their Series A funding round raising $42,000,000 in funding from Data Collective (lead investor), AME Cloud Ventures, DFJ, Genoa Ventures, Two Sigma Ventures, True Ventures, SciFI VC, Obvious Ventures, Innovation Endeavors, and Jenny Rooke. 

Zymergen completes $130 million dollar Series B funding round.

On October 11, 2016 Zymergen completed their Series B funding round raising $130,000,000 in funding from Soft Bank (lead investor), Two Sigma, Tao Capital Partners, Prelude Ventures, Obvious Ventures, Innovation Endeavors, ICONIQ Capital, Data Collective, DFJ, and AME Cloud Ventures. 

Zymergen acquires Radiant Genomics

On January 8, 2018 Zymergen acquired a functional metagenomics research company named Radiant Genomics. With this acquisition Zymergens gets to add the metagenomic technologies and genetic libraries developed by Radiant Genomics to it's core platform. Zymergen hopes acquiring Radiant Genomics will help accelerate it's ability to identify and create useful organisms and molecules.  The CEO of Zymergen had the following to say about the acquisition of radiant genomics "Radiant has built an unparalleled platform and set of libraries to search genetic diversity that will allow us to search for these molecules of interest, extending our ability to produce useful molecules for materials that can transform the world around us."